BiotechTube
CathWorks

CathWorks

Irvine, United States· Est.
cath.works
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

CathWorks is a private, commercial-stage medical technology company focused on revolutionizing physiologic assessment in coronary interventions. Its core product, the FFRangio System, leverages artificial intelligence and computational science to derive fractional flow reserve (FFR) values from standard angiographic images, eliminating the procedural complexities and costs associated with invasive pressure wires and adenosine. The company is actively commercializing in the US and internationally, supported by clinical validation studies and growing adoption at leading heart centers. CathWorks operates at the intersection of cardiovascular devices, AI, and digital health, targeting a significant segment of the coronary diagnostic market.

Cardiovascular

Technology Platform

AI and computational fluid dynamics software that analyzes routine coronary angiograms to provide wire-free, drug-free fractional flow reserve (FFR) values for the entire coronary tree.

Opportunities

The global shift towards physiology-guided PCI, supported by clinical guidelines, creates a large addressable market.
The wire-free, drug-free value proposition addresses key cost, workflow, and patient comfort barriers that have limited traditional FFR adoption.
Growth in AI adoption in healthcare and the trend towards value-based care provide favorable tailwinds for the platform.

Risk Factors

Faces competition from established invasive FFR wire companies and other angiogram-derived FFR solutions.
Market adoption risk hinges on changing physician behavior and securing favorable reimbursement.
As a private company, it is dependent on continued access to capital to fund commercial expansion and clinical trials.

Competitive Landscape

CathWorks competes in the coronary physiology assessment market against traditional pressure wire systems from major players like Abbott (PressureWire™), Boston Scientific (COMET™), and Philips (Verrata™ Wire). It also faces competition from other image-based FFR technologies, such as Siemens Healthineers' angio-FFR solution and various CT-FFR software providers (e.g., HeartFlow). Its key differentiator is providing comprehensive, intraprocedural FFR without a wire or drugs.

More companies in Diagnostics & Precision Medicine →More companies in United States →